Photo-acoustic signal enhancement with microbubble-based contrast agents

US10271733B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10271733-B2
Application numberUS-201113995711-A
CountryUS
Kind codeB2
Filing dateDec 12, 2011
Priority dateDec 22, 2010
Publication dateApr 30, 2019
Grant dateApr 30, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Bubbles (118-122) are utilized in some embodiments as part of a photoacoustic contrast agent (162) and, in some embodiments, to localize one or more locations (126-38) of a source of acoustic energy. The bubbles, such as microbubbles, can be used in proximity of nanoparticles of a first photoacoustic contrast agent, thereby affording a second photoacoustic contrast agent. The bubbles can intercept and re-radiate acoustic energy emitted by light-based activation of the first photoacoustic contrast agent in the immediate vicinity of the bubbles. As a further option, if the nanoparticles permeate further to tissue structures but remain in close enough proximity, their positions can be triangulated by the nearby bubbles, based on direction (144-148) and time delays (150-160) of ultrasound received by a transducer array.

First claim

Opening claim text (preview).

The invention claimed is: 1. A photoacoustic system for imaging contrast agents, the system comprising: an ultrasound imaging array configured to transmit ultrasound into a site within a patient tissue comprising a mixture of an ultrasound contrast agent and a photoacoustic contrast agent; a laser configured to generate a laser pulse to activate the photoacoustic contrast agent; and a computer operatively coupled to the ultrasound imaging array and the laser, the computer configured to: control the laser to generate the laser pulse so as to activate the photoacoustic contrast agent that is separately free-floating from the ultrasound contrast agent, wherein the activated photoacoustic contrast agent causes the ultrasound contrast agent to generate ultrasound; control the ultrasound imaging array to receive ultrasound transmitted from the ultrasound contrast agent; determine (1) time delays between the laser pulse and times when the ultrasound from the ultrasound contrast agent is received by the ultrasound imaging array and (2) angles in relation to a surface of the array that represent a direction in which the ultrasound transmitted from the ultrasound contrast agent impinges the array; and based on the time delays and the angles, triangulate a location of the photoacoustic contrast agent in the patient tissue. 2. The photoacoustic system of claim 1 , wherein the computer comprises a controller configured to control at least one of the generation of the laser pulse and the operation of the ultrasound imaging array of the system. 3. The photoacoustic system of claim 1 , further comprising a dispenser for delivering the ultrasound contrast agent and photoacoustic contrast agent to the patient. 4. The photoacoustic system of claim 3 , wherein the dispenser is configured to deliver the ultrasound contrast agent and the photoacoustic contrast agent to the patient as a mixture. 5. The photoacoustic system of claim 1 , wherein the computer is configured to control the laser to repeatedly transmit laser pulses, and wherein the computer is further configured to control the ultrasound imaging array to transmit ultrasound from the imaging array to the patient tissue intermittently with the laser pulses.

Assignees

Inventors

Classifications

  • Microbubbles, hollow microspheres, free gas bubbles, gas microspheres · CPC title

  • for diagnosis of the heart · CPC title

  • involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream · CPC title

  • A61B5/0095Primary

    by applying light and detecting acoustic waves, i.e. photoacoustic measurements · CPC title

  • characterised by features of the ultrasound transducer · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10271733B2 cover?
Bubbles (118-122) are utilized in some embodiments as part of a photoacoustic contrast agent (162) and, in some embodiments, to localize one or more locations (126-38) of a source of acoustic energy. The bubbles, such as microbubbles, can be used in proximity of nanoparticles of a first photoacoustic contrast agent, thereby affording a second photoacoustic contrast agent. The bubbles can interc…
Who is the assignee on this patent?
Shi William Tao, Jankovic Ladislav, Koninklijke Philips Nv
What technology area does this patent fall under?
Primary CPC classification A61B5/0095. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).